“ The main reason for the company’s financial success is our driven and loyal workforce which has gone above and beyond during the COVID-19 crisis, in addition… ”
In Conversation
“ The main challenge for orphan drugs in Spain is access, which has become highly complex in recent years ”
“ Plasma-derived therapies are unique life-saving treatments based on a very special and finite raw material, therefore regulations should take this into account ”
“ mAbxience has a different business model than the majority of big biosimilars producers which have vast sales and marketing capabilities. We have a business-to-business (B2B) model,… ”
“ Genmab has strong, focused investment into its pipeline and capabilities and is now transitioning into a fully-integrated commercial company. We have made lots of progress, but… ”
“ It takes an average of seven years for a patient to see an audiologist from the onset of their hearing loss. However, the impact on the… ”
“ We have observed big improvements in terms of trust [in biosimilars] from both healthcare professionals and patients [in Spain] in the last few years ”
“ This region, and especially Denmark, is a beacon to the rest of the group for upcoming trends as well as a sandbox in which new solutions… ”
“ Clinical trials address a triple bottom line: increasing health, increasing knowledge, and increasing business ”
“ We want to go from a business-to-business (B2B) model ... to a business-to-consumer (B2C) specialty pharma model by having our own sales organization in key European… ”
“ The pandemic showed us the importance of putting patients at the centre, but we must ensure that they continue having access to medicines. If we all… ”
“ Countries that have been hit hard by the pandemic, especially in southern Europe, are now much more eager to learn from Denmark and our digitalised systems ”
